Does the anti-migraine drug rizatriptan affect early neural tube development in chick embryos?

dc.contributor.authorSayin M.
dc.contributor.authorGurgen G.S.
dc.contributor.authorSayin S.S.
dc.contributor.authorGuvenc G.
dc.contributor.authorYuceer N.
dc.date.accessioned2025-04-10T11:07:42Z
dc.date.available2025-04-10T11:07:42Z
dc.date.issued2019
dc.description.abstractAIM: To investigate the impact of rizatriptan on neural tube development using early chick embryos as a model organism. MATERIAL and METHODS: A total of 36 pathogen-free Leghorn chicken eggs were selected and categorized in three groups: sham, therapeutic, and supra-therapeutic. After 24 hours, the eggs were opened and injected with sterile drugs, and then reclosed using plastic tape. After a period of 72 hours, the eggs were opened and assessed using the Hamburger-Hamilton chick embryology classification method. TUNEL staining was used to identify apoptosis, and hematoxylin-eosin staining was used to investigate neural tube closure. RESULTS: Treatment with rizatriptan significantly slowed down neural tube development. The supra-therapeutic group showed neural tube closure defects. CONCLUSION: Rizatriptan had a negative effect on neural tube closure. Further research is needed to identify a safe and effective drug for treating migraines during pregnancy. © 2019 Turkish Neurosurgical Society.
dc.identifier.DOI-ID10.5137/1019-5149.JTN.23431-18.1
dc.identifier.urihttp://hdl.handle.net/20.500.14701/47546
dc.publisherTurkish Neurosurgical Society
dc.titleDoes the anti-migraine drug rizatriptan affect early neural tube development in chick embryos?
dc.typeArticle

Files